Similar articles for PMID: 15911861

Year	Number of Results
1993	1
1996	2
1997	4
1998	2
1999	2
2000	2
2001	4
2002	6
2003	4
2004	8
2005	14
2006	23
2007	15
2008	11
2009	15
2010	12
2011	8
2012	11
2013	6
2014	3
2015	6
2016	7
2017	6
2018	7
2019	9
2020	2
2021	4
2022	3
2024	0

1

Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?

Koren G, Matsui D, Einarson A, Knoppert D, Steiner M. Koren G, et al. CMAJ. 2005 May 24;172(11):1457-9. doi: 10.1503/cmaj.1041100. CMAJ. 2005. PMID: 15911861 Free PMC article. Review. No abstract available.

2

[Adverse effects of selective serotonin reuptake inhibitors use during the third trimester of pregnancy and prevention guidelines].

Mejías C, Rodríguez-Pinilla E, Fernández Martín P, Martínez-Frías ML. Mejías C, et al. Med Clin (Barc). 2007 Apr 21;128(15):584-9. doi: 10.1157/13101615. Med Clin (Barc). 2007. PMID: 17462198 Review. Spanish.

3

Diagnosis and management of poor neonatal adaptation syndrome in newborns exposed in utero to selective seretonin/norepinephrine reuptake inhibitors.

Koren G, Finkelstein Y, Matsui D, Berkovich M. Koren G, et al. J Obstet Gynaecol Can. 2009 Apr;31(4):348-350. doi: 10.1016/S1701-2163(16)34157-3. J Obstet Gynaecol Can. 2009. PMID: 19497154 No abstract available.

4

Adverse effects in neonates exposed to SSRIs and SNRI in late gestation--Motherisk Update 2008.

Koren G, Boucher N. Koren G, et al. Can J Clin Pharmacol. 2009 Winter;16(1):e66-7. Epub 2009 Jan 22. Can J Clin Pharmacol. 2009. PMID: 19164848 Review.

5

Fetal and neonatal effects of maternal drug treatment for depression.

Belik J. Belik J. Semin Perinatol. 2008 Oct;32(5):350-4. doi: 10.1053/j.semperi.2008.08.001. Semin Perinatol. 2008. PMID: 18929158 Review.

6

[Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].

de Moor RA, Mourad L, ter Haar J, Egberts AC. de Moor RA, et al. Ned Tijdschr Geneeskd. 2003 Jul 12;147(28):1370-2. Ned Tijdschr Geneeskd. 2003. PMID: 12892015 Dutch.

7

Antidepressants during pregnancy: new research on fetal outcomes raises questions.

Thomas SP. Thomas SP. Issues Ment Health Nurs. 2005 Feb-Mar;26(2):115-6. doi: 10.1080/01612840590901563. Issues Ment Health Nurs. 2005. PMID: 15962918 No abstract available.

8

SSRI use during pregnancy.

Tran H, Robb AS. Tran H, et al. Semin Perinatol. 2015 Nov;39(7):545-7. doi: 10.1053/j.semperi.2015.08.010. Epub 2015 Oct 1. Semin Perinatol. 2015. PMID: 26428019 Review.

9

Do Maternal Pharmacogenetics Impact the Neonatal Abstinence Syndrome Following In Utero Exposure to Antidepressant Medications?

Shea AK, Wang DY, Snelgrove JW, Dalfen A, Hewko S, Murphy KE. Shea AK, et al. J Obstet Gynaecol Can. 2021 Jun;43(6):726-732. doi: 10.1016/j.jogc.2020.09.026. Epub 2020 Nov 5. J Obstet Gynaecol Can. 2021. PMID: 33303407

10

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W. Oberlander TF, et al. J Clin Psychiatry. 2004 Feb;65(2):230-7. doi: 10.4088/jcp.v65n0214. J Clin Psychiatry. 2004. PMID: 15003078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

180 results

Results by year